Tear evaporation is the primary driver in the majority of cases of DED1-4
Patients with dry eye disease (DED) are significantly more likely to report problems with performing everyday activities, such as3:
A survey of 2171 patients with DED found:
Signs and symptoms caused diminished performance at work
DED has a substantial economic burden—the annual direct costs are estimated at $3.84 billion with annual indirect costs estimated at
With ~38 million Americans affected today, the scope of DED is growing7,8
In addition to an increase in the overall prevalence of DED, many eye care professionals (ECPs) have observed an increase in younger adult patients (18 to 34 years old) over the past decade, as well as in modern lifestyle factors that further complicate the multifactorial nature of the disease.9
In a different survey of over 1000 ECPs9:
76% of ECPs reported an increase in patients between the ages of 18 and 34 with DED symptoms compared with 10 years ago
92% of ECPs reported that the use of modern technology was contributing to DED symptoms
89% of ECPs agreed that DED is becoming more common due to today’s multiscreen lifestyle
—Sheri Rowen, MD
An examination of the mechanisms of DED establishes that tear evaporation is contributing to the impact of DED.1,2
Review select literature expanding on the burden of DED
Patient-reported burden of dry eye disease in the United States: results of an online cross-sectional survey
Dana R, et al. Am J Ophthalmol. 2020
Sign up to stay informed about dry eye disease (DED), find out what your peers think about managing DED, and get updates about the advancements that Bausch + Lomb is pursuing.